Midterm outcomes of transmyocardial laser revascularization with intramyocardial injection of adipose derived stromal cells for severe refractory angina.

scientific article published on 19 June 2018

Midterm outcomes of transmyocardial laser revascularization with intramyocardial injection of adipose derived stromal cells for severe refractory angina. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5114/AIC.2018.76409
P932PMC publication ID6041827
P698PubMed publication ID30008770

P50authorJerzy SadowskiQ11725354
Bogusław KapelakQ60837570
Dhanunjaya LakkireddyQ88048131
Jacek PiatekQ94665139
Krzysztof BartuśQ114079238
Janusz Konstanty-KalandykQ114090105
P2093author name stringRandall Lee
Venkat Vuddanda
Anna Kędziora
P2860cites workThe Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 StudyQ22241915
Transmyocardial laser revascularization versus medical therapy for refractory anginaQ24241454
Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015)Q26748751
Cell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac RegenerationQ26765916
Stem Cells and Regenerative Medicine: Myth or Reality of the 21th CenturyQ26795447
Adipose tissue-derived stem cells as a therapeutic tool for cardiovascular diseaseQ26795749
Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study designQ26822936
Transmyocardial revascularization devices: technology updateQ26865489
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010Q27860791
Adipose Tissue-Derived Stem Cells in Regenerative MedicineQ28071698
Human adipose tissue is a source of multipotent stem cellsQ29617385
Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-AnalysisQ30729604
Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survivalQ33298019
Improved cell survival in infarcted myocardium using a novel combination transmyocardial laser and cell delivery systemQ33320858
IFATS collection: Human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac functionQ34114841
Long-Term Outcomes After Transmyocardial RevascularizationQ34352991
Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activityQ34544884
The combined use of transmyocardial laser revascularisation and intramyocardial injection of bone-marrow derived stem cells in patients with end-stage coronary artery disease: one year follow-upQ34779939
Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-AnalysisQ34804229
Fatality, morbidity and quality of life in patients with refractory angina pectorisQ35010712
Predictors of long-term clinical endpoints in patients with refractory anginaQ35135665
Differential effects of culture senescence and mechanical stimulation on the proliferation and leiomyogenic differentiation of MSC from different sources: implications for engineering vascular grafts.Q35386693
Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis.Q37849930
Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences.Q38226693
Adipose-derived Mesenchymal Stem Cells and Their Reparative Potential in Ischemic Heart DiseaseQ38509646
Current State of Stem Cell Therapy for Ischemic Heart DiseaseQ38697092
The Celution(®) System: Automated Processing of Adipose-Derived Regenerative Cells in a Functionally Closed SystemQ41761877
Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the DepartQ43408475
Stem Cell Therapy Is a Promising Tool for Refractory Angina: A Meta-analysis of Randomized Controlled TrialsQ44493479
The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.Q46102792
Non-PCI/CABG therapies for refractory anginaQ47702501
Secretion of angiogenic and antiapoptotic factors by human adipose stromal cellsQ48012614
Hypoxic preconditioning enhances survival of human adipose-derived stem cells and conditions endothelial cells in vitro.Q50263126
Efficacy of cyclosporine A-nanoparticles emulsion combined with stem cell transplantation therapy for acute myocardial infarctionQ53092514
Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemiaQ83089220
First Experience in Humans Using Adipose Tissue–Derived Regenerative Cells in the Treatment of Patients With ST-Segment Elevation Myocardial InfarctionQ83333593
Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE TrialQ88127754
Old methods of myocardial revascularization to treat refractory anginaQ88174561
P433issue2
P921main subjectrevascularizationQ7317735
P304page(s)176-182
P577publication date2018-06-19
P1433published inPostępy w Kardiologii InterwencyjnejQ26853806
P1476titleMidterm outcomes of transmyocardial laser revascularization with intramyocardial injection of adipose derived stromal cells for severe refractory angina
P478volume14

Search more.